newsfilter
← Latest News
GlobeNewswire·

Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update

- Positive 6 Month Clinical Data Reported for Ongoing Pediatric Netherton Syndrome Study - FDA Clears Second Pivotal Study of QRX003 for Netherton Syndrome - Initial Positive Data Announced from Peeling Skin